Keyword: Berkeley

CRISPR a potential cure for sickle cell disease

Sickle cell disease is caused by a mutation in the gene that codes for the protein beta-globin, a component of red blood cells. A group of physicians and researchers have used CRISPR/Cas9 editing to correct the mutation in stem cells taken from the blood of affected patients.

Early genetic cancer biomarkers reveal best treatment path

In treating cancer patients, a wide variety of options exists, and one of the hurdles for a physician is to determine which treatment is most suitable for each individual. And now a team at Berkeley Lab has devised a scoring system by which to make these decisions based on genetic factors.